Bellerophon Therapeutics
BLPH
#10592
Rank
S$0.18 M
Marketcap
S$0.01547
Share price
-36.84%
Change (1 day)
-80.88%
Change (1 year)

Bellerophon Therapeutics (BLPH) Fails to deliver data

Key failure to deliver metrics for Bellerophon Therapeutics :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Bellerophon Therapeutics (BLPH) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Bellerophon Therapeutics (BLPH) - since 2020

Volume in USD (price x number of shares), data since 2020

Bellerophon Therapeutics (BLPH) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024S$0.01 M-99.89%
2023S$11.94 M1116.91%
2022S$0.98 M-89.54%
2021S$9.37 M-14.98%
2020S$11.03 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Baxter
BAX
S$26.96 MS$86.01 M๐Ÿ‡บ๐Ÿ‡ธ USA
Abeona Therapeutics
ABEO
S$6.24 MS$9.06 M๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
S$34.98 MS$0.43 B๐Ÿ‡บ๐Ÿ‡ธ USA
Lantheus Holdings
LNTH
S$7.75 MS$47.1 M๐Ÿ‡บ๐Ÿ‡ธ USA